Active Not Recruiting OBSERVATIONAL NCT07391592
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert (NitrX)
Sponsor: MicroPort Orthopedics Inc.
Conditions
Arthritis Knee Avascular Necrosis Joint Diseases Osteoarthitis Rheumatoid Arthritis of Knee
Interventions
EVOLUTION® NitrX™
Updated 1 time since 2026 Last updated: Feb 2, 2026 Started: Aug 18, 2025 Primary completion: Dec 31, 2032 Completion: Dec 31, 2032
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Arthritis Knee and Avascular Necrosis and is currently ongoing. MicroPort Orthopedics Inc. leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- MicroPort Orthopedics Inc.
Data source: MicroPort Orthopedics Inc.
For direct contact, visit the study record on ClinicalTrials.gov .